Marquette General Cancer Center

 

Urinary Tract

 

Study Name - CALGB 90601

 

Study Description -

A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab (IND #7921, NSC #704865) to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma

 

IRB Open Date - 07/15/2009

 

Consent

 

Data Privacy Statement for Research Studies

 

 

 

 

 

 

 

<< Back